We've detected that Javascript is not enabled. It is required for an optimal survey taking experience.
Please check your browser's settings and make sure Javascript is turned on. Learn how to enable Javascript.

Skip survey header

Eyes Forward: Navigating Advances in Pharmacokinetics and Anti-VEGF Therapy

1. Please rate how well you think the session met the stated learning objectives below

At the end of this session, I am able to: *This question is required.

Space Cell	Strongly disagree	Disagree	Neutral	Agree	Strongly agree
Examine the pharmacokinetic properties of anti-VEGF agents and their role in the management of retinal diseases, including AMD, DME, and RVO.	Examine the pharmacokinetic properties of anti-VEGF agents and their role in the management of retinal diseases, including AMD, DME, and RVO.: Strongly disagree	Examine the pharmacokinetic properties of anti-VEGF agents and their role in the management of retinal diseases, including AMD, DME, and RVO.: Disagree	Examine the pharmacokinetic properties of anti-VEGF agents and their role in the management of retinal diseases, including AMD, DME, and RVO.: Neutral	Examine the pharmacokinetic properties of anti-VEGF agents and their role in the management of retinal diseases, including AMD, DME, and RVO.: Agree	Examine the pharmacokinetic properties of anti-VEGF agents and their role in the management of retinal diseases, including AMD, DME, and RVO.: Strongly agree
Analyze real-world case scenarios to develop evidence-based treatment approaches for patients with diverse retinal conditions, considering the latest advancements in anti-VEGF therapy.	Analyze real-world case scenarios to develop evidence-based treatment approaches for patients with diverse retinal conditions, considering the latest advancements in anti-VEGF therapy.: Strongly disagree	Analyze real-world case scenarios to develop evidence-based treatment approaches for patients with diverse retinal conditions, considering the latest advancements in anti-VEGF therapy.: Disagree	Analyze real-world case scenarios to develop evidence-based treatment approaches for patients with diverse retinal conditions, considering the latest advancements in anti-VEGF therapy.: Neutral	Analyze real-world case scenarios to develop evidence-based treatment approaches for patients with diverse retinal conditions, considering the latest advancements in anti-VEGF therapy.: Agree	Analyze real-world case scenarios to develop evidence-based treatment approaches for patients with diverse retinal conditions, considering the latest advancements in anti-VEGF therapy.: Strongly agree
Explore the scientific rationale behind treatment modalities aiming to optimize treatment regimens and improve long-term visual outcomes.	Explore the scientific rationale behind treatment modalities aiming to optimize treatment regimens and improve long-term visual outcomes.: Strongly disagree	Explore the scientific rationale behind treatment modalities aiming to optimize treatment regimens and improve long-term visual outcomes.: Disagree	Explore the scientific rationale behind treatment modalities aiming to optimize treatment regimens and improve long-term visual outcomes.: Neutral	Explore the scientific rationale behind treatment modalities aiming to optimize treatment regimens and improve long-term visual outcomes.: Agree	Explore the scientific rationale behind treatment modalities aiming to optimize treatment regimens and improve long-term visual outcomes.: Strongly agree
Evaluate the influence of emerging research and pharmacokinetic data on clinical decision-making processes regarding anti-VEGF therapy, emphasizing patient-centric care and the durability of treatment strategies.	Evaluate the influence of emerging research and pharmacokinetic data on clinical decision-making processes regarding anti-VEGF therapy, emphasizing patient-centric care and the durability of treatment strategies.: Strongly disagree	Evaluate the influence of emerging research and pharmacokinetic data on clinical decision-making processes regarding anti-VEGF therapy, emphasizing patient-centric care and the durability of treatment strategies.: Disagree	Evaluate the influence of emerging research and pharmacokinetic data on clinical decision-making processes regarding anti-VEGF therapy, emphasizing patient-centric care and the durability of treatment strategies.: Neutral	Evaluate the influence of emerging research and pharmacokinetic data on clinical decision-making processes regarding anti-VEGF therapy, emphasizing patient-centric care and the durability of treatment strategies.: Agree	Evaluate the influence of emerging research and pharmacokinetic data on clinical decision-making processes regarding anti-VEGF therapy, emphasizing patient-centric care and the durability of treatment strategies.: Strongly agree

2. The session met the following CanMEDS roles: *This question is required.

Space Cell	Strongly disagree	Disagree	Neutral	Agree	Strongly agree
Medical Expert	Medical Expert: Strongly disagree	Medical Expert: Disagree	Medical Expert: Neutral	Medical Expert: Agree	Medical Expert: Strongly agree
Scholar	Scholar: Strongly disagree	Scholar: Disagree	Scholar: Neutral	Scholar: Agree	Scholar: Strongly agree

3. Based on this session, I will pursue additional learning on the following topics: *This question is required.

4. Based on this session, I will make the following changes to my practice: *This question is required.

5. Would you recommend this session topic for next year’s conference? Please explain : *This question is required.

6. Please rate the following statements: *This question is required.

Space Cell	Strongly disagree	Disagree	Neutral	Agree	Strongly agree
The content was relevant to my learning needs	The content was relevant to my learning needs: Strongly disagree	The content was relevant to my learning needs: Disagree	The content was relevant to my learning needs: Neutral	The content was relevant to my learning needs: Agree	The content was relevant to my learning needs: Strongly agree
The teaching methods were effective	The teaching methods were effective: Strongly disagree	The teaching methods were effective: Disagree	The teaching methods were effective: Neutral	The teaching methods were effective: Agree	The teaching methods were effective: Strongly agree
There was adequate time for questions and answers	There was adequate time for questions and answers: Strongly disagree	There was adequate time for questions and answers: Disagree	There was adequate time for questions and answers: Neutral	There was adequate time for questions and answers: Agree	There was adequate time for questions and answers: Strongly agree
The session was a suitable length	The session was a suitable length: Strongly disagree	The session was a suitable length: Disagree	The session was a suitable length: Neutral	The session was a suitable length: Agree	The session was a suitable length: Strongly agree
The speakers were engaging	The speakers were engaging: Strongly disagree	The speakers were engaging: Disagree	The speakers were engaging: Neutral	The speakers were engaging: Agree	The speakers were engaging: Strongly agree
The presentations were non-biased	The presentations were non-biased: Strongly disagree	The presentations were non-biased: Disagree	The presentations were non-biased: Neutral	The presentations were non-biased: Agree	The presentations were non-biased: Strongly agree

If bias was perceived, please describe: *This question is required.

7. Additional comments: